Oaktree Acquisition Corp. III Life Sciences appoints David A. Berry as director
PositiveFinancial Markets

Oaktree Acquisition Corp. III Life Sciences has appointed David A. Berry as its new director, a move that signals the company's commitment to strengthening its leadership in the life sciences sector. Berry's extensive experience and expertise are expected to drive innovation and growth, making this appointment a significant step forward for the organization.
— Curated by the World Pulse Now AI Editorial System